Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus- associated non-Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 14, Issue 11, 1996, Pages 3026-3035

  Sparano, J A ^a   Wiernik, P H ^a   Hu, X ^a   Sarta, C ^a   Schwartz, E L ^a   Soeiro, R ^a   Henry, D H ^a   Mason, B ^a   Ratech, H ^a   Dutcher, J P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DIDANOSINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD CULTURE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; ERYTHROCYTE TRANSFUSION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MALE; MENINGITIS; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; THROMBOCYTE TRANSFUSION; VIRUS CULTURE;

EID: 10344236461     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.11.3026     Document Type: Article

References (40)

1. Rabkin CS, Yellin F: Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 86:22:1711-1716, 1994
2. Gail MH, Pluda JM, Rabkin CS, et al: Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst 83:695-700, 1991
3. Pluda JM, Venzon DJ, Tosato G, et al: Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 11:1099-1107, 1993
4. Knowles DM, Chamulak GA, Subar M, et al: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 108:744-753. 1988
5. Gill PS, Levine AM, Krailo M, et al: AIDS-related malignant lymphoma: Results of prospective treatment trials. J Gin Oncol 5:1322-1328, 1987
6. Levine AM, Wernz JC, Kaplan L, et al: Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. JAMA 266:84-88, 1991
7. Kaplan LD, Abrams DI, Feigal E, et al: AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 261:719-724, 1989
8. Kaplan LD, Kahn JO, Crowne S, et al: Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-related non-Hodgkin's lymphoma: Results of a randomized trial. J Clin Oncol 9:929-940, 1990
9. Tirelli U, Errante U, Oksenhendler E, et al: Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poor-prognosis AIDS-related non-Hodgkin's lymphoma. French-Italian Cooperative Study Group. Ann Oncol 3:843-847, 1992
10. Gisselbrecht C, Oksenhendler E, Tirelli U, et al: Human immunodeficiency virus-related lymphoma: Treatment with intensive combination chemotherapy. Am J Med 95:188-196, 1993
11. Remick SC, McSharry JJ, Wolf BC, et al: Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma. J Clin Oncol 11:1691-1702, 1993
12. Kaplan L, Straus D, Testa M, et al: Randomized trial of standard dose m-BACOD vs reduced dose m-BACOD for systemic HIV-associated lymphoma: ACTG 142. Proc Am Soc Clin Oncol 14:288, 1995 (abstr 818)
13. Sparano JA, Wiernik PH, Strack M, et al: Infusional cyclophosphamide, doxorubicin, and etoposide in HIV- and HTLV-I-related non-Hodgkin's lymphoma: A highly active regimen. Blood 81:2810-2815, 1993
14. Sparano JA, Wiernik PH, Strack M, et al: Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: A follow up report of a highly active regimen. Leuk Lymphoma 14:263-271, 1994
15. Tirelli U, Errante D, Vaccher E, et al: Treatment of HIV-related non-Hodgkin's lymphoma with chemotherapy and G-CSF: Reduction in the days of hospitalization and toxicity with concomitant overall reduction in cost. Proc Am Soc Clin Oncol 12:53, 1993 (abstr 13)
16. Faulds D, Brogden RN: Didanosine. Drugs 44:94-116, 1992
17. Kahn JO, Lagakos SW, Richman D, et al: A controlled trial comparing continued zidovudine and didanosine in human immunodeficiency virus infection. N Engl J Med 327:581-587. 1992
18. Schacter LP, Rozencweig M, Beltangady M, et al: Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease. Blood 80:2969-2976, 1992
19. National Cancer Institute Sponsored Study of Classifications of non-Hodgkin's Lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
20. Lokich JJ, Zipoli TE, Moore C, et al: Doxorubicin/vinblastine and doxorubicin/cyclophosphamide combination chemotherapy by continuous infusion. Cancer 58:1020-1023, 1986
21. Strife FR, Jardine I: Analysis of the anticancer drugs VP16-213 and VM-26 and their metabolites by high-pressure liquid chromatography. J Chormatogr 182:211-220, 1980
22. Gupta PA, Enrico A, Armstrong J, et al: A semiquantitative microassay for measurement of relative number on blood mononuclear cells infected with human immunodeficiency virus. AIDS Res Hum Retro 6:1193-1196, 1990
23. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982
24. Levine AM, Gill PS, Krailo M, et al: Natural history of persistent generalized adenopathy in gay men: Risk of lymphoma and factors associated with development of lymphoma. Blood 68:130a, 1986 (abstr)
25. Canellos GP: Residual mass in lymphoma may not be residual disease. J Clin Oncol 6:931-933, 1988
26. Rosner B: Fundamentals of Biostatistics (ed 4). New York, NY, Duxbury, 1995, pp 272-355
27. SAS/INSIGHT User's Guide (ed 2, version 6). Cary, NC, SAS Institute, 1993
28. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
29. Revision of the CDC Surveillance Case Definition for Acquired Immunodeficiency Syndrome. MMWR 36:3S-15S, 1987 (suppl 1S)
30. Ballem PJ, Belzberg A, Devine DV, et al: Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 327:1779-1784, 1992
31. Folks TM, Kessler SW, Grenstein JM, et al: Infections and replication of human immunodeficiency virus-1 (HIV-1) in highly purified progenitor cells from normal human bone marrow. Science 242:919-922, 1988
32. Zucker-Franklin D, Cao Y: Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. Proc Natl Acad Sci USA 86:5595-5599, 1989
33. Ganser A: Abnormalities of hematopoiesis in acquired immunodeficiency syndrome. Blut 56:49-53, 1988
34. Louache F, Henri A, Bettaieb A, et al: Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 80:2991-2999, 1992
35. Hande KR: Etoposide pharmacology. Semin Oncol 19:3-9, 1992 (suppl 13)
36. Gallo JM, Finco TS, Swagler AR, et al: Pharmacokinetic evaluation of drug interactions with anti-HIV drugs, II effect of 2′,3′-dideoxyinosine (DDI) on zidovudine kinetics in monkeys. AIDS Res Hum Retro 8:277-283, 1992
37. Mackall CL, Fleisher TA, Brown MR, et al: Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after lintensive chemotherapy. N Engl J Med 332:143-149, 1995
38. von Boehmer H: The developmental biology of T lymphocytes. Annu Rev Immunol 6:309-326, 1988
39. Pantaleo G, Graziosi C, Fauci AS: The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327-335, 1993
40. Todd J: Quantitation of human immunodeficiency virsu plasma RNA by branched DNA and reverse transcription coupled polymerase chain reaction assay methods: A critical evaluation of accuracy and reproducibility. Serodian Immunother Infect Disease 6:233-239, 1994